428 related articles for article (PubMed ID: 17341430)
1. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
[TBL] [Abstract][Full Text] [Related]
2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
3. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
4. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
5. Malignant Müllerian mixed tumor of the ovary associated with yolk sac tumor, neuroepithelial and trophoblastic differentiation (teratoid carcinosarcoma).
García-Galvis OF; Cabrera-Ozoria C; Fernández JA; Stolnicu S; Nogales FF
Int J Gynecol Pathol; 2008 Oct; 27(4):515-20. PubMed ID: 18753971
[TBL] [Abstract][Full Text] [Related]
6. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
7. Clear cell carcinoma simulating the "endometrioid-like variant" of yolk sac tumor.
Ballotta MR; Bianchini E; Borghi L; Fortini RM
Pathologica; 1995 Feb; 87(1):87-90. PubMed ID: 7567174
[TBL] [Abstract][Full Text] [Related]
8. Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
Matsuura Y; Kitajima M; Hachisuga T; Tanimoto A; Okura N; Kihara I
J Obstet Gynaecol Res; 2010 Aug; 36(4):907-11. PubMed ID: 20666968
[TBL] [Abstract][Full Text] [Related]
9. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report.
McBee WC; Brainard J; Sawady J; Rose PG
Gynecol Oncol; 2007 Apr; 105(1):244-7. PubMed ID: 17316775
[TBL] [Abstract][Full Text] [Related]
10. Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Maida Y; Kyo S; Takakura M; Kanaya T; Inoue M
Gynecol Oncol; 1998 Oct; 71(1):133-6. PubMed ID: 9784334
[TBL] [Abstract][Full Text] [Related]
11. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
12. Malignant squamous cell elements in the ovarian cancer: report of 5 cases and review of the literature.
Kuwashima Y; Uehara T; Kishi K; Nishimura T; Shiromizu K; Matsuzawa M; Takayama S
In Vivo; 1994; 8(6):1063-6. PubMed ID: 7772738
[TBL] [Abstract][Full Text] [Related]
13. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
[TBL] [Abstract][Full Text] [Related]
14. Ovarian endometrioid carcinoma with yolk sac tumor component in a postmenopausal woman.
Kabukcuoglu S; Arik D
Eur J Gynaecol Oncol; 2016; 37(6):867-869. PubMed ID: 29943939
[TBL] [Abstract][Full Text] [Related]
15. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
16. [Clear cell carcinoma of the ovary simulating a yolk sac tumor].
Bahri I; Boudawara T; Khabir A; Beyrouti MI; Frikha M; Jlidi R
Ann Pathol; 2003 Apr; 23(2):165-8. PubMed ID: 12843973
[TBL] [Abstract][Full Text] [Related]
17. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
[TBL] [Abstract][Full Text] [Related]
18. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Ulbright TM
Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
[TBL] [Abstract][Full Text] [Related]
19. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
20. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
